Table 3.

Rank probabilities of each treatment for different outcome measures based on network

Drug	Rank 1	Rank 2	Rank 3	Rank 4
(A) PFS
Alectinib	1.00	0.00	0.00	0.00
Ceritinib	0.00	0.14	0.86	0.00
Crizotinib	0.00	0.86	0.35	0.00
Chemotherapy	0.00	0.00	0.00	1.00
(B) ORR
Alectinib	0.76	0.20	0.03	0.00
Ceritinib	0.22	0.52	0.26	0.00
Crizotinib	0.02	0.28	0.70	0.00
Chemotherapy	0.00	0.00	0.00	1.00
(C) DCR
Alectinib	0.51	0.33	0.13	0.03
Ceritinib	0.41	0.25	0.28	0.06
Crizotinib	0.08	0.41	0.49	0.02
Chemotherapy	0.00	0.01	0.10	0.89
(D) Discontinuation rate
Alectinib	0.03	0.06	0.30	0.61
Ceritinib	0.06	0.23	0.34	0.36
Crizotinib	0.14	0.52	0.31	0.03
Chemotherapy	0.76	0.18	0.05	0.01

DCR, disease control rate; ORR, overall response rate; PFS, progression‐free survival.